PETER JONES to Diabetes Mellitus, Type 2
This is a "connection" page, showing publications PETER JONES has written about Diabetes Mellitus, Type 2.
Connection Strength
0.196
-
Clinical significance of recent lipid trials on reducing risk in patients with type 2 diabetes mellitus. Am J Cardiol. 2007 Feb 19; 99(4A):133B-140B.
Score: 0.132
-
Safety of Alirocumab (A PCSK9 Monoclonal Antibody) from 14 Randomized Trials. Am J Cardiol. 2016 Dec 15; 118(12):1805-1811.
Score: 0.065